XML 61 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
License agreements - Calithera (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 01, 2018
Jan. 30, 2017
Mar. 31, 2017
Jan. 31, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Jan. 01, 2017
License agreements                    
Long term investment         $ 131,330   $ 131,330   $ 134,356 [1]  
Research and development expense         298,089 $ 201,786 601,192 $ 609,706    
Net income         52,394 (12,484) 11,254 (199,567)    
Unrealized (gain) loss on long term investments         (34,641) (19,574) (11,962) (25,388)    
Calithera                    
License agreements                    
Funding of future development costs (as a percent)       70.00%            
Upfront payment made under license agreement       $ 45,000            
Potential milestone payments to be made with profit sharing in effect       430,000            
Potential milestone payments to be made with profit sharing terminated       $ 750,000            
Milestone payment made under license agreement     $ 12,000              
Research and development expense         3,200 2,000 5,800 3,600    
Calithera | Accrued and other liabilities                    
License agreements                    
Accrued and other liabilities         2,800   2,800      
Calithera | U.S.                    
License agreements                    
Percentage of profit (losses)       60.00%            
Calithera                    
License agreements                    
Milestone payment made under license agreement     $ 12,000              
Total consideration paid   $ 53,000                
Long term investment         $ 8,600   $ 8,600   14,400  
Ownership percentage (as a percent)         5.00%   5.00%      
Calithera | Other Comprehensive Income                    
License agreements                    
Unrealized (gain) loss on long term investments         $ (2,200) 5,700 $ (5,800) 13,900    
Calithera | Calithera | Accrued and other liabilities                    
License agreements                    
Accrued and other liabilities                 $ 900  
Calithera | Stock purchase agreement                    
License agreements                    
Purchase of common stock under Stock Purchase Agreement (in shares )       1.7            
Purchase price of common stock                   $ 8,000
Per share price   $ 6.75               $ 4.65
Fair market value of our long term investments   $ 11,600                
Stock purchase price       $ 8,000            
Long term investment           $ 11,600   11,600    
Research and development expense               $ 41,400    
Calithera | Collaboration and license agreement                    
License agreements                    
Upfront license fees       $ 45,000            
Calithera | ASU 2016-01                    
License agreements                    
Net income $ 2,800                  
[1] The condensed consolidated balance sheet at December 31, 2017 has been derived from the audited financial statements at that date.